Surgery Partners Tracking Toward Midpoint of 2025 Same-Store Revenue Growth, RBC Says

MT Newswires Live11-12

Surgery Partners (SGRY) is still tracking toward the midpoint of its 4% to 6% same-store revenue growth guidance in 2025, even as softening commercial volume is "concerning," RBC Capital Markets said in a note emailed Tuesday.

While the company does not assume the volume and commercial mix headwinds will continue in the longer term, it is monitoring for potential implications for its 2026 plans, RBC said.

With Surgery Partners lowering its 2025 guidance range, RBC said it was not "overly concerned" by the guide-down, especially with an active pipeline of opportunities into next year and organic growth still tracking to the midpoint of the company's long-term target.

The firm maintained its outperform rating on the company and lowered its price target to $31 from $35.

Price: 16.41, Change: +0.38, Percent Change: +2.34

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2582393286?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 00:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582393286","market":"fut","top_or_hot":-1,"title":"Surgery Partners Tracking Toward Midpoint of 2025 Same-Store Revenue Growth, RBC Says","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SGRY\">Surgery Partners</a> (SGRY) is still tracking toward the midpoint of its 4% to 6% same-store revenue growth guidance in 2025, even as softening commercial volume is \"concerning,\" RBC Capital Markets said in a note emailed Tuesday.</p><p>While the company does not assume the volume and commercial mix headwinds will continue in the longer term, it is monitoring for potential implications for its 2026 plans, RBC said.</p><p>With Surgery Partners lowering its 2025 guidance range, RBC said it was not \"overly concerned\" by the guide-down, especially with an active pipeline of opportunities into next year and organic growth still tracking to the midpoint of the company's long-term target.</p><p>The firm maintained its outperform rating on the company and lowered its price target to $31 from $35.</p><p>Price: 16.41, Change: +0.38, Percent Change: +2.34</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Surgery Partners Tracking Toward Midpoint of 2025 Same-Store Revenue Growth, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSurgery Partners Tracking Toward Midpoint of 2025 Same-Store Revenue Growth, RBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-11-12 00:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SGRY\">Surgery Partners</a> (SGRY) is still tracking toward the midpoint of its 4% to 6% same-store revenue growth guidance in 2025, even as softening commercial volume is \"concerning,\" RBC Capital Markets said in a note emailed Tuesday.</p><p>While the company does not assume the volume and commercial mix headwinds will continue in the longer term, it is monitoring for potential implications for its 2026 plans, RBC said.</p><p>With Surgery Partners lowering its 2025 guidance range, RBC said it was not \"overly concerned\" by the guide-down, especially with an active pipeline of opportunities into next year and organic growth still tracking to the midpoint of the company's long-term target.</p><p>The firm maintained its outperform rating on the company and lowered its price target to $31 from $35.</p><p>Price: 16.41, Change: +0.38, Percent Change: +2.34</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SGRY","symbol_name":"Surgery Partners, Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2582393286","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582393286","pubTimestamp":1762878281,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Surgery Partners  is still tracking toward the midpoint of its 4% to 6% same-store revenue growth guidance in 2025, even as softening commercial volume is \"concerning,\" RBC Capital Markets said in a note emailed Tuesday.While the company does not assume the volume and commercial mix headwinds will continue in the longer term, it is monitoring for potential implications for its 2026 plans, RBC said.With Surgery Partners lowering its 2025 guidance range, RBC said it was not \"overly concerned\" by the guide-down, especially with an active pipeline of opportunities into next year and organic growth still tracking to the midpoint of the company's long-term target.The firm maintained its outperform rating on the company and lowered its price target to $31 from $35.Price: 16.41, Change: +0.38, Percent Change: +2.34","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SGRY":"Surgery Partners, Inc."},"translate_title":"加拿大皇家银行(RBC)表示，外科合作伙伴正在跟踪2025年同店收入增长中点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGRY":1.5},"content_text":"Surgery Partners (SGRY) is still tracking toward the midpoint of its 4% to 6% same-store revenue growth guidance in 2025, even as softening commercial volume is \"concerning,\" RBC Capital Markets said in a note emailed Tuesday.While the company does not assume the volume and commercial mix headwinds will continue in the longer term, it is monitoring for potential implications for its 2026 plans, RBC said.With Surgery Partners lowering its 2025 guidance range, RBC said it was not \"overly concerned\" by the guide-down, especially with an active pipeline of opportunities into next year and organic growth still tracking to the midpoint of the company's long-term target.The firm maintained its outperform rating on the company and lowered its price target to $31 from $35.Price: 16.41, Change: +0.38, Percent Change: +2.34","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2582393286","isCrawlerRequest":true}